Details for Patent: 5,540,930
✉ Email this page to a colleague
Summary for Patent: 5,540,930
| Title: | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
| Abstract: | The invention provides novel compositions of matter containing water-insoluble steroid drugs suitable for therapeutic use. The invention provides stable aqueous suspensions of water-insoluble steroid drugs of particle sizes of .ltoreq.15 .mu.m which remain in such a state so as to allow for immediate suspension, when desired, even after extended periods of settling. |
| Inventor(s): | Guy; Yaacov J. (Rehovot, IL), Friedman; Doron I. (Carmei Yosef, IL) |
| Assignee: | Pharmos Corporation (New York, NY) |
| Application Number: | 08/142,743 |
|
Patent Claim Types: see list of patent claims | Composition; Use; |
Drugs Protected by US Patent 5,540,930
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,540,930
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 217523 | ⤷ Sign Up | |||
| Australia | 697617 | ⤷ Sign Up | |||
| Australia | 7983594 | ⤷ Sign Up | |||
| Brazil | 9407958 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
